Observational studyThe Journal of international medical research2026
Etiology, surgical management, and outcomes of patients with scleral thinning.
Observational study in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to analyze the etiological spectrum, surgical management strategies, and clinical outcomes of patients with scleral thinning and summarize individualized treatment principles based on lesion characteristics and systemic conditions. In this retrospective observational case series of 14 patients (16 eyes) diagnosed with scleral thinning, patient data on demographics, etiology, clinical presentation, surgical details, and outcomes were collected. Treatment strategies were individualized based on lesion location, extent, corneal involvement, and conjunctival status. Etiologies were congenital (18.75%), surgery/trauma-related (43.75%), immune-mediated (18.75%), inflammatory (12.5%), and idiopathic (6.25%), with four cases involving multiple factors. Surgical repair was performed in 11 eyes using scleral patch grafts (18.2%), anterior lamellar corneal grafts (45.4%), or double lamellar keratoplasty (36.4%), with adjunctive procedures (conjunctival flap or amniotic membrane transplantation) performed in 6 cases. Globe integrity was successfully restored in all surgical cases with normal intraocular pressure. Final best-corrected visual acuity improved or remained stable in 9 of the 11 cases. Four cases developed postoperative graft rejection or melting, which was associated with systemic autoimmune activity or poor medication adherence, with two requiring surgical reintervention. Management of scleral thinning requires a comprehensive etiological assessment and an individualized surgical plan based on lesion characteristics. Postoperative outcomes appear to be influenced by systemic immune status and patient compliance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.